Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Kayo Umekawa"'
Autor:
Hirohiko Hasegawa, Masaharu Kanaoka, Kazuto Yamazaki, Yasuyuki Ueki, Kayo Umekawa, Naohito Ohashi
Publikováno v:
Bioorganic & Medicinal Chemistry Letters. 12:1275-1278
A novel non-peptidyl endothelin converting enzyme inhibitor was obtained through a pharmacophore analysis of known inhibitors and three-dimensional structure database search. Analogues of the new inhibitor were designed using the structure-activity r
Autor:
Kayo Umekawa, Hirohiko Hasegawa, Yasuo Matsumura, Kimihiko Sato, Yasushi Tsutsumi, Naohito Ohashi
Publikováno v:
Japanese Journal of Pharmacology. 84:7-15
We describe the pharmacological characteristics of SM-19712 (4-chloro-N-[[(4-cyano-3-methyl-1-phenyl-1H-pyrazol-5-yl)amino]carbonyl] benzenesulfonamide, monosodium salt). SM-19712 inhibited endothelin converting enzyme (ECE) solubilized from rat lung
Autor:
Kayo Umekawa, Naohito Ohashi, Masaharu Kanaoka, Hirohiko Hasegawa, Kazuto Yamazaki, Yasuyuki Ueki
Publikováno v:
ChemInform. 33
Autor:
Yasuo Matsumura, Kayo Umekawa, Naohito Ohashi, Toshihiko Kuro, Masanori Takaoka, Yutaka Kobayashi
Publikováno v:
Japanese journal of pharmacology. 84(1)
Effects of SM-19712 {4-chloro-N-[[(4-cyano-3-methyl-1-phenyl-lH-pyrazol-5-yl)amino]carbonyl] benzenesulfonamide, monosodium salt}, a novel endothelin converting enzyme (ECE) inhibitor, on ischemic acute renal failure (ARF) in rats were examined in co